Breast cancer treatments contribute to aging acceleration in survivors

A new research paper was published by Aging (Aging-US) on March 7, 2025, titled “Accelerated aging associated with cancer characteristics and treatments among breast cancer survivors.”

Study shows how heteroresistance can act as a precursor to antibiotic resistance

A new study shows how heteroresistance, a transient resistance common in many bacteria, can act as a precursor to the development of antibiotic resistance.

March 18, 2024

Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer

Treatment with the investigational bispecific antibody ubamatamab (REGN4018) alone or in combination with the PD-1 inhibitor cemiplimab (Libtayo) appeared to be safe and demonstrated activity

November 29, 2023

Recipharm CEO anticipates 2024 will be ‘as hard’ for CDMOs, strategy will be key for endurance

Recipharm CEO Marc Funk anticipates 2024 to be just as challenging for CDMOs in terms of finding opportunities for growth due to wider economic challenges.

October 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.